Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)


You May Also Like

Cyclacel Pharmaceuticals to Release First Quarter 2017 Financial Results

BERKELEY HEIGHTS, N.J., May 05, 2017 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ...

Aptevo Therapeutics and Alligator Bioscience Announce Plans to Co-Develop Novel Bispecific Antibody for Tumor-Directed Immunotherapy

Strategic Partnership Will Advance Development of a Novel BispecificImmuno-Oncology Antibody Targeting Compelling Biological PathwayImplicated ...